ClinicalTrialsFinder

HMG-CoA Reductase Inhibitor Toxicity Clinical Trials in Daejeon

1 recruitingDaejeon, South Korea

Showing 1–1 of 1 trials

Recruiting
Phase 4

Low Dose Rosuvastatin Plus Ezetimibe Versus High-dose Rosuvastatin in AMI

Myocardial InfarctionStatin Adverse ReactionHMG-CoA Reductase Inhibitor Toxicity
Kiyuk Chang, MD,PhD3,548 enrolled7 locationsNCT04499859